Viemed Healthcare Inc. (VMD) Insider Trading

Last 12 months

Insiders sold $1.59M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. President Michael Moore sold $1.24M on Mar 20, 7.2% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2024.

Net open-market

−$1.59M

0 buys · 3 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 3

executives and directors

Last open-market buy

May 2024

May 14, 2024

Get an email when VMD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 25	William Frazier Chief Medical Officer	SoldNo plan	10,000	$11.72	$117k	12%	Form 4
Jun 24	Timothy Smokoff Director	SoldNo plan 5 parts	20,000	$11.50 average	$230k	21%	Form 4
Mar 18 – 20	Michael Moore President	SoldNo plan 3 parts	136,802	$9.05 average	$1.24M	7.2%	Form 4
Aug 13, 2025	Jerome Cambre Vice President of Sales	SoldNo plan 2 parts	4,880	$7.32 average	$36k	5.5%	Form 4
Aug 12, 2025	Michael Moore President	SoldNo plan	50,090	$7.33	$367k	2.6%	Form 4
Jun 27, 2025 – Jun 30, 2025	Michael Moore President	SoldNo plan 3 parts	181,316	$6.92 average	$1.26M	8.7%	Form 4
Jun 30, 2025	Nitin Kaushal Director	SoldNo plan	7,048	$6.91	$49k	5.3%	Form 4
Jun 26, 2025 – Jun 27, 2025	Nitin Kaushal Director	SoldNo plan 2 parts	42,952	$7.01 average	$301k	25%	Form 4
Mar 13, 2025 – Mar 14, 2025	Timothy Smokoff Director	SoldNo plan 5 parts	11,865	$7.70 average	$91k	13%	Form 4
Nov 25, 2024 – Nov 26, 2024	Nitin Kaushal Director	SoldNo plan 2 parts	30,000	$8.68 average	$260k	19%	Form 4
Nov 19, 2024 – Nov 20, 2024	Nitin Kaushal Director	SoldNo plan 2 parts	30,000	$8.53 average	$256k	19%	Form 4
Nov 13, 2024	Randy E. Dobbs Director	SoldNo plan	36,261	$9.28	$337k	25%	Form 4
Nov 11, 2024 – Nov 13, 2024	Nitin Kaushal Director	SoldNo plan 2 parts	60,000	$9.52 average	$571k	32%	Form 4

Jun 25No plan
William Frazier
Chief Medical Officer · sold 10,000 at $11.72
$117k
12% of stake
Jun 24No plan
Timothy Smokoff
Director · sold 20,000 at avg $11.50
$230k
21% of stake
Mar 18 – 20No plan
Michael Moore
President · sold 136,802 at avg $9.05
$1.24M
7.2% of stake
Aug 13, 2025No plan
Jerome Cambre
Vice President of Sales · sold 4,880 at avg $7.32
$36k
5.5% of stake
Aug 12, 2025No plan
Michael Moore
President · sold 50,090 at $7.33
$367k
2.6% of stake
Jun 27, 2025 – Jun 30, 2025No plan
Michael Moore
President · sold 181,316 at avg $6.92
$1.26M
8.7% of stake
Jun 30, 2025No plan
Nitin Kaushal
Director · sold 7,048 at $6.91
$49k
5.3% of stake
Jun 26, 2025 – Jun 27, 2025No plan
Nitin Kaushal
Director · sold 42,952 at avg $7.01
$301k
25% of stake
Mar 13, 2025 – Mar 14, 2025No plan
Timothy Smokoff
Director · sold 11,865 at avg $7.70
$91k
13% of stake
Nov 25, 2024 – Nov 26, 2024No plan
Nitin Kaushal
Director · sold 30,000 at avg $8.68
$260k
19% of stake
Nov 19, 2024 – Nov 20, 2024No plan
Nitin Kaushal
Director · sold 30,000 at avg $8.53
$256k
19% of stake
Nov 13, 2024No plan
Randy E. Dobbs
Director · sold 36,261 at $9.28
$337k
25% of stake
Nov 11, 2024 – Nov 13, 2024No plan
Nitin Kaushal
Director · sold 60,000 at avg $9.52
$571k
32% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch VMD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Misc Health & Allied Services, NEC

QIPTQuipt Home Medical Corp.

CCELCryo-Cell International Inc.

SHCSotera Health Company

PGNYProgyny Inc.

CONConcentra Group Holdings Inc.

DCGODocGo Inc.

OMDAOmada Health, Inc.

FLGTFulgent Genetics Inc.

Spot a number that looks wrong? Check it in VMD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing VMD

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.